|
Social determinants of health and utilization of neoadjuvant chemotherapy in patients with triple negative breast cancer (TNBC) in the community oncology setting. |
|
|
|
Consulting or Advisory Role - Immunomedics; Novartis; Pfizer; Seagen |
|
|
Employment - Ontada/McKesson |
|
|
Employment - Ontada/McKesson |
|
|
|
Consulting or Advisory Role - Myriad Genetics |
(OPTIONAL) Uncompensated Relationships - Clovis Oncology |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - McKesson; Moderna Therapeutics; Oncolytics (I) |
Honoraria - Bristol-Myers Squibb; Roche |
Consulting or Advisory Role - Advi; Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health |